| Autor: |
Gurram S; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, 400019, India., Jha DK; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, 400019, India., Shah DS; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, 400019, India., Kshirsagar MM; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, 400019, India., Amin PD; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, 400019, India. purnima.amin@yahoo.co.in. |
| Abstrakt: |
Probiotics have gained a lot of interest in recent years as an alternative as well as adjuvant therapy for several conditions owing to their health benefits. These live microorganisms have proven efficacy for treating gut disorders, inflammation, bacterial vaginosis, hepatic and depressive disorders, and many more. There are conventional as well as non-conventional formulations available for the delivery of probiotics with the latter having fewer regulatory guidelines. The conventional formulations include the pharmaceutical formulations specifically designed to deliver an efficacious number of viable microorganisms. Studies have indicated 10 8 -10 9 CFU/g as an ideal dose of probiotics for achieving health benefits, and hence, all the formulations must at least contain the said number of viable bacteria to show a therapeutic effect. The most crucial feature of probiotic formulations is that the bacteria are prone to several environmental and processing factors which all together reduce the viability of the bacteria in the final formulation. These factors include processing parameters like temperature, humidity, pressure, and storage conditions. Thus, the present review primarily focuses on the critical process parameters affecting the probiotic viability during stabilization process and formulation development. Understanding these factors prior to processing helps in delivering probiotics in the required therapeutic numbers at the target site. |
Full text from SpringerLink